Session Information
-
WCLC 2018
19th World Conference on Lung Cancer
Conference Program for the 19th World Conference on Lung Cancer in Toronto, Canada
Download PDF of the Abstract Book: Click Here.
Presentation Date(s):- Sept 23 - 26, 2018
- Total Presentations: 2391
September 23 Sun
Sep 23 Monday
September 24 Mon
Sep 24 Tuesday
September 25 Tue
Sep 25 Wednesday
September 26 Wed
Sep 26
-
+
MA03 - Lung Cancer Screening - Next Step
- 10:30 - 12:00
- 9/24/2018
- Location: Room 206 AC
- Type: Mini Oral Abstract Session
- Track: Screening and Early Detection
-
+
MA03.05 - New Subsolid Pulmonary Nodules in Lung Cancer Screening: The NELSON Trial
11:00 - 11:05 | Presenter: Marjolein A Heuvelmans | Author(s): Joan E Walter, Uraujh Yousaf-Khan, Monique Dorrius, Erik Thunnissen, Anna Schermann, Harry J.M. Groen, Carlijn M. Van Der Aalst, Kristiaan Nackaerts, Rozemarijn Vliegenthart, Harry J De Koning, Matthijs Oudkerk
- Abstract
Loading...
-
+
OA03 - Advances in Lung Cancer Pathology
- 10:30 - 12:00
- 9/24/2018
- Location: Room 205 BD
- Type: Oral Abstract Session
- Track: Pathology
-
+
OA03.03 - Phase 2B of Blueprint PD-L1 Immunohistochemistry Assay Comparability Study
10:50 - 11:00 | Presenter: Keith M Kerr | Author(s): Ming Sound Tsao, Yasushi Yatabe, Erik Thunnissen, Andrew G Nicholson, Andre Moreira, Teh-Ying Chou, Alain C. Borczuk, Lukas Bubendorf, Mari Mino-Kenudson, Johan Botling, Mary Beth Beasley, Lucian R Chirieac, Sanja Dacic, Sylvie Lantuejoul, Giuseppe Pelosi, Jin-Haeng Chung, Gang Chen, Prudence Russell, Claudia Poleri, Jennifer Sauter, Hui Yu, Masayuki Noguchi, Ignacio I. Wistuba, Melania Pintilie, Murry W Wynes, Fred R. Hirsch
- Abstract
Loading...
-
+
MS10 - Part Solid Nodules, GGN and STAS
- 15:15 - 16:45
- 9/24/2018
- Location: Room 206 F
- Type: Mini Symposium
- Track: Treatment of Early Stage/Localized Disease
-
+
MS10.02 - Importance of CT in the Pathologic Assessment of Tumor Sized in Subsolid and Part-Solid Adenocarcinoma
15:30 - 15:45 | Presenter: Erik Thunnissen
- Abstract
No abstract available for this presentation
-
+
MA26 - New Therapies and Emerging Data in ALK, EGFR and ROS1
- 13:30 - 15:00
- 9/26/2018
- Location: Room 201 BD
- Type: Mini Oral Abstract Session
- Track: Targeted Therapy
-
+
MA26.06 - Crizotinib-Treated ALK Immunopositive Metastasized NSCLC is Associated with an Unfavorable Prognosis when FISH Negative
14:05 - 14:10 | Presenter: Erik Thunnissen | Author(s): Birgit Lissenberg-Witte, Michel Van Den Heuvel, Kim Monkhorst, Birgit G Skov, Jens B Sorensen, Anders Mellemgaard, Anne-Marie C. Dingemans, ErnstJan Speel, Joop de Langen, Sayed MS Hashemi, Idris Bahce, Miep Van Der Drift, Reinhard Büttner, Monika Looijen_salomon, John Roy Gosney, Pieter E. Postmus, Suzi Samii, Fabrice Duplaquet, Brigit Weynand, Xavier Durando, Frederique Penault-Llorca, Stephen P Finn, Buge Aysim Oz, Nalan Akyurek, Jürgen Wolf, Lukas Bubendorf, Annemieke Hiemstra, Sylvia Duin, Ivonne Marondel, Wim Timens, Ed MD Schuuring, Patrick Pauwels, Egbert F Smit
- Abstract
Loading... -
+
MA26.07 - ROS1 (SP384) Immunohistochemistry Inter-Reader Precision Between 12 Pathologists
14:10 - 14:15 | Presenter: Keith M Kerr | Author(s): Amy Elizabeth Hanlon Newell, Wen-Wei Liu, Lukas Bubendorf, Reinhard Büttner, Mark Kockx, Myriam Kossai, Fernando Lopez-Rios, Antonio Marchetti, Ivonne Marondel, Andrew G Nicholson, Buge Aysim Oz, Patrick Pauwels, Frederique Penault-Llorca, Giulio Rossi, Vanessa Rüsseler, Erik Thunnissen, Greg Pate, Bryce Portier, Claire Faure, Catherine H Le, Derek Smith, Ina Menzl, Richard S.P. Huang
- Abstract
Loading...